-
公开(公告)号：EP2288612B1
公开(公告)日：2015-07-29
申请号：EP09726806.4
申请日：2009-04-02
申请人： Gabather AB
IPC分类号： C07D487/04 , A61K31/519 , A61P25/20 , A61P25/22
CPC分类号： C07D487/04 , A61K31/519
-
22.发明授权NOVEL FLAVONOL COMPOUNDS, A BIOACTIVE EXTRACT/FRACTION FROM ULMUS WALLICHIANA AND ITS COMPOUNDS FOR PREVENTION FOR TREATMENT OF OSTEO-HEALTH RELATED DISORDERS 有权NOVEL黄酮醇化合物，生物活性提取物/ FRAGMENT FROM榆树及其化合物用于骨条件相关疾病的预防和治疗
公开(公告)号：EP2265595B1
公开(公告)日：2015-07-22
申请号：EP09718537.5
申请日：2009-03-03
发明人： MAURYA, Rakesh , RAWAT, Preeti , SHARAN, Kunal , SIDDIQUI, Jawed, Akhtar , SWARNKAR, Gaurav , MISHRA, Geetanjali , MANICKAVASAGAM, Lakshmi , ARYA, Kamal, Ram , CHATTOPADHYAY, Naibedya , JAIN, Girish, Kumar .
IPC分类号： C07D309/10 , A61K31/352 , A61P19/10
CPC分类号： C07H7/06 , C07D405/04
-
公开(公告)号：EP2867673A1
公开(公告)日：2015-05-06
申请号：EP13813945.6
申请日：2013-06-27
IPC分类号： G01N33/53 , C07D333/24 , C12Q1/04 , G01N33/569
CPC分类号： G01N33/5308 , C07D333/24 , C07D409/14 , G01N33/50 , G01N33/52 , G01N33/582 , G01N33/68 , G01N2400/00 , G01N2400/12 , G01N2400/40
摘要： The present invention relates to a method for detection, identification and/or quantification of one or more carbohydrates. The method comprises the steps of contacting an objector a sample with a luminescent conjugated oligothiophene (LCO) and detecting at least one detection signal of the luminescent conjugated oligothiophene. The presence of and/or the identity of and/or the quantity of one or more carbohydrates that is or are present on said object or in said sample is determined based on said detected detection signal from the LCO. The invention encompasses methods for carbohydrate detection by use of oligothiopene derivatives. The methods are quick, easy and direct and can be performed in real time as well as in situ.
-
公开(公告)号：EP2836221A2
公开(公告)日：2015-02-18
申请号：EP13775223.4
申请日：2013-04-12
申请人： L&F Health LLC
IPC分类号： A61K31/724
CPC分类号： A61K31/724 , A61K31/155 , A61K31/455 , A61K38/00 , A61K38/28 , A61K45/06 , A61K2300/00
摘要： Described are methods for using cyclodextrin to treat, inhibit, prevent, ameliorate, or cure diabetes or conditions relating to diabetes.
-
25.发明授权MOLYBDENUM (IV) AMIDE PRECURSORS AND USE THEREOF IN ATOMIC LAYER DEPOSITION 有权钼（IV）-AMIDVORLÄUFER及其USE IN核位置分离
公开(公告)号：EP2609102B1
公开(公告)日：2014-12-31
申请号：EP11752057.7
申请日：2011-08-25
IPC分类号： C07F11/00 , C07F17/00 , C23C16/40 , C23C16/455 , B05D1/00
CPC分类号： B05D1/60 , C07F11/00 , C07F17/00 , C23C16/405 , C23C16/45525
摘要： Molybdenum (IV) amide complexes are disclosed herein corresponding in structure to Formula (I): wherein: L is -NR1R2; R1 and R2 are C1-C6-alkyl or hydrogen; R is C1-C6-alkyl; and n is zero, 1, 2 or 3. Further, methods of forming MoO2 films by atomic layer deposition (ALD) using Formula (I) complexes and Mo[N(Me)(Et)]4 are disclosed herein.
-
26.发明公开3-HYDROXYANTHRANILIC ACID (3-HAA) THERAPY FOR PREVENTION AND TREATMENT OF HYPERLIPIDEMIA AND ITS CARDIOVASCULAR COMPLICATIONS 有权疗法-3-羟基-2-氨基（3- HAA）心血管并发症及其高脂血症的预防和治疗
公开(公告)号：EP2736505A1
公开(公告)日：2014-06-04
申请号：EP12820828.7
申请日：2012-07-13
申请人： Hansson, Göran K.
发明人： KETELHUTH, Daniel
IPC分类号： A61K31/196 , A61P3/06
CPC分类号： A61K31/196
摘要： The present invention relates to the use of a tryptophan metabolite, 3- hydroxyanthranilic acid (3-HAA)or a functional analogue thereof, for prophylactic and/or therapeutic treatment of mammals, in special humans, against hyperlipidemia and its cardiovascular complications, i.e atheroma formation, myocardial infarction and heart failure, ischemic stroke and transient ischemic attacks, renal impairment, aortic aneurysms and critical limb ischemia caused by atherosclerosis.
摘要翻译： 本发明涉及使用色氨酸代谢物，3-羟基邻氨基苯甲酸（3-HAA）或其功能类似物的，其用于哺乳动物的预防和/或治疗性治疗，在特殊人类，对高脂血症和其心血管并发症，即 动脉粥样硬化形成，心肌梗死和心脏衰竭，缺血性卒中和短暂性脑缺血发作，肾功能不全，主动脉瘤和动脉粥样硬化引起的严重肢体缺血。
-
公开(公告)号：EP2242722B1
公开(公告)日：2014-03-26
申请号：EP08789942.3
申请日：2008-09-04
-
公开(公告)号：EP2704730A1
公开(公告)日：2014-03-12
申请号：EP12779872.6
申请日：2012-05-02
申请人： Cocky Smart Pty Ltd
发明人： CHAMBERLAIN, John
摘要： A method for treating or preventing microbial skin infections comprising the step of: administering to a subject in need thereof a composition comprising avian extract EP-2 in a therapeutically effective concentration together with a pharmaceutically acceptable carrier and/or diluent.
-
29.发明公开PROCESS FOR CONTINUOUS FLOW SYNTHESIS OF BETA-AMINO CROTONATE 有权VERFAHRENFÜRKONTINUIERLICHE合成VON BETA-AMINO-CROTONAT
公开(公告)号：EP2702035A2
公开(公告)日：2014-03-05
申请号：EP12729240.7
申请日：2012-04-25
IPC分类号： C07C227/06 , C07C229/30
CPC分类号： C07C227/06 , C07C229/30
摘要： Beta aminocrotonates are important intermediates for the synthesis of Ca channel blockers. The processes available in the art are batch processes with yields about 85%. There are no continuous processes available for the synthesis of such compounds. This gap in the art is addressed by the invention by disclosing a continuous process resulting in high yields of beta amino crotonates.
摘要翻译： β-氨基巴豆酸钠是合成Ca通道阻滞剂的重要中间体。 本领域可获得的方法是分批方法，产率约85％。 没有可用于合成这种化合物的连续方法。 本发明通过公开连续的方法解决了本领域的这种差距，导致β-氨基巴豆酸酯的高产率。
-
30.发明公开A METHOD OF SCREENING ANTI-TUBERCULAR COMPOUNDS 审中-公开筛选 - VERFAHRENFÜRVERBINDUNGEN GEGEN TUBERKULOSE
公开(公告)号：EP2686687A2
公开(公告)日：2014-01-22
申请号：EP12716669.2
申请日：2012-03-16
发明人： SARKAR, Dhiman , SARKAR, Sampa
IPC分类号： G01N33/68
CPC分类号： C12Q1/18 , G01N33/5695 , G01N2333/35 , G01N2500/04
摘要： Novel targets for screening anti tubercular targets and methods to use those targets to screen potential drugs for anti tubercular therapy are addressed through this invention. A method of screening anti-tubercular compounds that affect the binding between GroEL2 protein or a fragment thereof and a kit for screening of antitubercular drug candidates having an isolated gro EL 2 protein; Mts- Atf-Biotin Label Transfer Reagents and a culture medium comprising M. bovis BCG (ATCC 35745), M. smegmatis (ATCC 607) are disclosed.
摘要翻译： 用于筛选抗结核靶标的新目标和使用这些靶标筛选潜在药物用于抗结核治疗的方法通过本发明来解决。 筛选影响GroEL2蛋白或其片段之间的结合的抗结核化合物和用于筛选具有分离的gro EL2蛋白的抗结核药物候选物的试剂盒的方法; Mts-Atf-生物素标记转移试剂和包含牛分枝杆菌BCG（ATCC 35745），耻垢分枝杆菌（ATCC 607）的培养基。
-
-
-
-
-
-
-
-
-
搜索结果
142 条记录 (耗时 0.026 秒)
